SN

Sitakanta Nayak

Active Director Director DIN 10924137
DIN 10924137 First appointment Jan 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sitakanta Nayak

Data last updated:

Sitakanta Nayak is a Director at Carexa India Private Limited (since 2025) and Director at Starline Ventures Private Limited (since 2025).

DIN 10924137
Primary Designation Director
First Appointment 27 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Carexa India Private Limited U86100OD2025FTC051330
Director10 Nov 20252025Active
Starline Ventures Private Limited U68100OD2025PTC047925
Director27 Jan 20252025Active

Board colleagues of Sitakanta Nayak

Directorship timeline

Open interactive timeline →
Carexa India Private Limited
Starline Ventures Private Limited
Premium access

Shareholding and investment profile for Sitakanta Nayak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sitakanta Nayak

Sitakanta Nayak currently holds 2 directorships: Carexa India Private Limited (Director, since 10 Nov 2025); Starline Ventures Private Limited (Director, since 27 Jan 2025).

Sitakanta Nayak was first appointed on 27 Jan 2025 as Director at Starline Ventures Private Limited.

The current boards of Sitakanta Nayak's companies include Barada Kanta Nayak (Carexa India Private Limited), Shaktikanta Nayak (Carexa India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available